Home › NDC Lookup › RxCUI directory › RxCUI 1944535

Abuse-Deterrent oxycodone hydrochloride 15 MG Oral Tablet [Roxybond] — RxCUI 1944535

RxNorm drug concept · Semantic branded drug
RxCUI 1944535 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1944535
Official nameAbuse-Deterrent oxycodone hydrochloride 15 MG Oral Tablet [Roxybond]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRoxyBond 15 MG Oral Tablet
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)1,841 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxycodone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Extended-release oxycodone is designed for pain that's severe enough to need steady, around-the-clock control — not just occasional flare-ups. The tablet releases slowly over 12 ho...
  • Why has my doctor prescribed an extended-release opioid instead of regular pain pills?
  • No — and this is really important. Crushing, breaking, chewing, or dissolving the tablet destroys the controlled-release mechanism. The entire dose, meant to be released slowly ove...
  • Is it okay to crush or break the tablet to make it easier to swallow?
📖 Read our full Oxycodone guide →

🕸️ Concept Web — How Abuse-Deterrent oxycodone hydrochloride 15 MG Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Abuse-Deterrent oxycodone hydrochloride 15 MG Oral Tablet [Roxybond] RxCUI 1944535

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Oxycodone 7804
    • Oxycodone hydrochloride 82063
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Roxybond 1944530
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxycodone Oral Tablet 373198
    • Oxycodone hydrochloride Oral Tablet 2645384
    • Oxycodone Oral Product 1161682
    • Oxycodone Pill 1161683
    • Oxycodone hydrochloride Oral Product 2663026
    • Oxycodone hydrochloride Pill 2661812
    • Oxycodone Oral Tablet [Roxybond] 1944532
    • Oxycodone hydrochloride Oral Tablet [Roxybond] 2656119
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Abuse-Deterrent oxycodone hydrochloride 15 MG Oral Tablet SCD · 1944529
  • Oxycodone hydrochloride 15 MG SCDC · 1049542
  • Oxycodone Oral Tablet SCDF · 373198
  • Oxycodone hydrochloride Oral Tablet SCDFP · 2645384
  • Oxycodone Oral Product SCDG · 1161682
  • Oxycodone Pill SCDG · 1161683
  • Oxycodone hydrochloride Oral Product SCDGP · 2663026
  • Oxycodone hydrochloride Pill SCDGP · 2661812

Brand-Name Concepts

  • Oxycodone hydrochloride 15 MG [Roxybond] SBDC · 1944531
  • Oxycodone Oral Tablet [Roxybond] SBDF · 1944532
  • Oxycodone hydrochloride Oral Tablet [Roxybond] SBDFP · 2656119
  • Roxybond Oral Product SBDG · 1944533
  • Roxybond Pill SBDG · 1944534
  • Roxybond BN · 1944530

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1944535 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81140-0101-10 100 TABLET, COATED in 1 BOTTLE (81140-101-10) RoxyBond Protega Pharmaceuticals Inc 2023-12-19
81140-0102-10 100 TABLET, COATED in 1 BOTTLE (81140-102-10) RoxyBond Protega Pharmaceuticals Inc 2023-12-19
81140-0103-10 100 TABLET, COATED in 1 BOTTLE (81140-103-10) RoxyBond Protega Pharmaceuticals Inc 2023-12-19
81140-0104-10 100 TABLET, COATED in 1 BOTTLE (81140-104-10) RoxyBond Protega Pharmaceuticals Inc 2023-12-19
Observed labelers: Protega Pharmaceuticals Inc (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.